Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells

Clara Contaldo, Timothy J. Myers, Cinzia Zucchini, Maria Cristina Manara, Claudia Chiodoni, Mario P. Colombo, Giordano Nicoletti, Pier Luigi Lollini, Tieshi Li, Lara Longobardi, Katia Scotlandi, Anna Spagnoli

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The insulin-like growth factor-1 system, including its critical mediator insulin receptor substrate-1 (IRS-1), is involved in regulating osteosarcoma (OS) cell proliferation or differentiation. The aim of this study is to define the role of IRS-1 in OS cells by assessing the contribution of IRS-1 in the differentiation of human and murine OS cell lines and mouse mesenchymal stem cells (MSCs) and found that the basal level of IRS-1 is important for the initiation of differentiation. Both down-regulation and over-expression of IRS-1 inhibited osteoblastic differentiation. In vivo studies showed that OS cells over-expressing IRS-1 have increased metastatic potential and tumor growth. The proteasome inhibitor MG-132 led to an increase in IRS-1 protein level that inhibited osteoblastic differentiation, suggesting a role for proteasomal regulation in maintaining the appropriate expression level of IRS-1. Thus, precise regulation of IRS-1 expression level is critical for determining the differentiating capacity of MSCs and OS cells, and that derangement of IRS-1 levels can be a critical step in OS transformation.

Original languageEnglish (US)
Pages (from-to)41-53
Number of pages13
JournalGrowth Factors
Volume32
Issue number1
DOIs
StatePublished - Feb 1 2014

Fingerprint

Insulin Receptor Substrate Proteins
Osteosarcoma
Stem cells
Mesenchymal Stromal Cells
Proteasome Inhibitors
Cell proliferation
Somatomedins
Tumors
Cell Differentiation
Down-Regulation
Cells
Cell Proliferation

Keywords

  • Insulin receptor substrate-1
  • Mesenchymal stem cells
  • Osteoblastic differentiation
  • Osteosarcoma

ASJC Scopus subject areas

  • Endocrinology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. / Contaldo, Clara; Myers, Timothy J.; Zucchini, Cinzia; Manara, Maria Cristina; Chiodoni, Claudia; Colombo, Mario P.; Nicoletti, Giordano; Lollini, Pier Luigi; Li, Tieshi; Longobardi, Lara; Scotlandi, Katia; Spagnoli, Anna.

In: Growth Factors, Vol. 32, No. 1, 01.02.2014, p. 41-53.

Research output: Contribution to journalArticle

Contaldo, C, Myers, TJ, Zucchini, C, Manara, MC, Chiodoni, C, Colombo, MP, Nicoletti, G, Lollini, PL, Li, T, Longobardi, L, Scotlandi, K & Spagnoli, A 2014, 'Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells', Growth Factors, vol. 32, no. 1, pp. 41-53. https://doi.org/10.3109/08977194.2013.870168
Contaldo, Clara ; Myers, Timothy J. ; Zucchini, Cinzia ; Manara, Maria Cristina ; Chiodoni, Claudia ; Colombo, Mario P. ; Nicoletti, Giordano ; Lollini, Pier Luigi ; Li, Tieshi ; Longobardi, Lara ; Scotlandi, Katia ; Spagnoli, Anna. / Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. In: Growth Factors. 2014 ; Vol. 32, No. 1. pp. 41-53.
@article{ececba8d0c1d4a3990d73b78aca1e94f,
title = "Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells",
abstract = "The insulin-like growth factor-1 system, including its critical mediator insulin receptor substrate-1 (IRS-1), is involved in regulating osteosarcoma (OS) cell proliferation or differentiation. The aim of this study is to define the role of IRS-1 in OS cells by assessing the contribution of IRS-1 in the differentiation of human and murine OS cell lines and mouse mesenchymal stem cells (MSCs) and found that the basal level of IRS-1 is important for the initiation of differentiation. Both down-regulation and over-expression of IRS-1 inhibited osteoblastic differentiation. In vivo studies showed that OS cells over-expressing IRS-1 have increased metastatic potential and tumor growth. The proteasome inhibitor MG-132 led to an increase in IRS-1 protein level that inhibited osteoblastic differentiation, suggesting a role for proteasomal regulation in maintaining the appropriate expression level of IRS-1. Thus, precise regulation of IRS-1 expression level is critical for determining the differentiating capacity of MSCs and OS cells, and that derangement of IRS-1 levels can be a critical step in OS transformation.",
keywords = "Insulin receptor substrate-1, Mesenchymal stem cells, Osteoblastic differentiation, Osteosarcoma",
author = "Clara Contaldo and Myers, {Timothy J.} and Cinzia Zucchini and Manara, {Maria Cristina} and Claudia Chiodoni and Colombo, {Mario P.} and Giordano Nicoletti and Lollini, {Pier Luigi} and Tieshi Li and Lara Longobardi and Katia Scotlandi and Anna Spagnoli",
year = "2014",
month = "2",
day = "1",
doi = "10.3109/08977194.2013.870168",
language = "English (US)",
volume = "32",
pages = "41--53",
journal = "Growth Factors",
issn = "0897-7194",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells

AU - Contaldo, Clara

AU - Myers, Timothy J.

AU - Zucchini, Cinzia

AU - Manara, Maria Cristina

AU - Chiodoni, Claudia

AU - Colombo, Mario P.

AU - Nicoletti, Giordano

AU - Lollini, Pier Luigi

AU - Li, Tieshi

AU - Longobardi, Lara

AU - Scotlandi, Katia

AU - Spagnoli, Anna

PY - 2014/2/1

Y1 - 2014/2/1

N2 - The insulin-like growth factor-1 system, including its critical mediator insulin receptor substrate-1 (IRS-1), is involved in regulating osteosarcoma (OS) cell proliferation or differentiation. The aim of this study is to define the role of IRS-1 in OS cells by assessing the contribution of IRS-1 in the differentiation of human and murine OS cell lines and mouse mesenchymal stem cells (MSCs) and found that the basal level of IRS-1 is important for the initiation of differentiation. Both down-regulation and over-expression of IRS-1 inhibited osteoblastic differentiation. In vivo studies showed that OS cells over-expressing IRS-1 have increased metastatic potential and tumor growth. The proteasome inhibitor MG-132 led to an increase in IRS-1 protein level that inhibited osteoblastic differentiation, suggesting a role for proteasomal regulation in maintaining the appropriate expression level of IRS-1. Thus, precise regulation of IRS-1 expression level is critical for determining the differentiating capacity of MSCs and OS cells, and that derangement of IRS-1 levels can be a critical step in OS transformation.

AB - The insulin-like growth factor-1 system, including its critical mediator insulin receptor substrate-1 (IRS-1), is involved in regulating osteosarcoma (OS) cell proliferation or differentiation. The aim of this study is to define the role of IRS-1 in OS cells by assessing the contribution of IRS-1 in the differentiation of human and murine OS cell lines and mouse mesenchymal stem cells (MSCs) and found that the basal level of IRS-1 is important for the initiation of differentiation. Both down-regulation and over-expression of IRS-1 inhibited osteoblastic differentiation. In vivo studies showed that OS cells over-expressing IRS-1 have increased metastatic potential and tumor growth. The proteasome inhibitor MG-132 led to an increase in IRS-1 protein level that inhibited osteoblastic differentiation, suggesting a role for proteasomal regulation in maintaining the appropriate expression level of IRS-1. Thus, precise regulation of IRS-1 expression level is critical for determining the differentiating capacity of MSCs and OS cells, and that derangement of IRS-1 levels can be a critical step in OS transformation.

KW - Insulin receptor substrate-1

KW - Mesenchymal stem cells

KW - Osteoblastic differentiation

KW - Osteosarcoma

UR - http://www.scopus.com/inward/record.url?scp=84893219406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893219406&partnerID=8YFLogxK

U2 - 10.3109/08977194.2013.870168

DO - 10.3109/08977194.2013.870168

M3 - Article

VL - 32

SP - 41

EP - 53

JO - Growth Factors

JF - Growth Factors

SN - 0897-7194

IS - 1

ER -